Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-247740
Filing Date
2021-08-16
Accepted
2021-08-16 16:15:49
Documents
12
Period of Report
2021-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K/A d218531d8ka.htm   iXBRL 8-K/A 25828
  Complete submission text file 0001193125-21-247740.txt   152084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210812.xsd EX-101.SCH 2529
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210812_lab.xml EX-101.LAB 18664
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210812_pre.xml EX-101.PRE 11680
5 EXTRACTED XBRL INSTANCE DOCUMENT d218531d8ka_htm.xml XML 4257
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50865 | Film No.: 211178382
SIC: 2834 Pharmaceutical Preparations